Escipra 5 Tablet contains Escitalopram Oxalate 5 mg, a selective serotonin reuptake inhibitor (SSRI) primarily indicated for the treatment of major depressive disorder (MDD) and generalized anxiety disorder (GAD). Escitalopram functions by increasing serotonin levels in the central nervous system, thereby enhancing mood and alleviating symptoms associated with depression and anxiety. It is prescribed to improve emotional well-being, reduce feelings of sadness, and restore interest in daily activities. The recommended dosage should be individualized based on patient response and tolerability, with a typical starting dose of 5 mg once daily, which may be adjusted by the healthcare provider. Escipra 5 is generally well tolerated; however, patients may experience side effects such as nausea, headache, insomnia, dry mouth, or dizziness. It is important to monitor for any signs of worsening depression, suicidal ideation, or unusual behavioral changes, especially during the initial treatment period or dose adjustments. Escipra 5 should be used with caution in patients with a history of bipolar disorder, seizures, or hepatic impairment. Abrupt discontinuation is not advised due to potential withdrawal symptoms; gradual dose tapering under medical supervision is recommended. This medication should be used under strict medical guidance, considering potential drug interactions and contraindications.